共 14 条
REDUCING ATTRITION THROUGH EARLY ASSESSMENT OF DRUG SAFETY, HIGHLIGHTS FROM THE SOCIETY OF MEDICINES RESEARCH SYMPOSIUM, HELD ON MARCH 13TH, 2014-NATIONAL HEART & LUNG INSTITUTE, KENSINGTON, LONDON, UK
被引:1
|作者:
Alderton, W.
[1
]
Holder, J.
[2
]
Lock, R.
[3
]
Pryde, D.
[4
]
机构:
[1] Abcodia Ltd, London W1T 4TP, England
[2] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England
[3] Takeda Dev Ctr Europe Ltd, London WC2B 4AE, England
[4] Pfizer Neusentis, Cambridge CB21 6GS, England
关键词:
Drug toxicity;
Risk management;
Bioinformatics;
Engineering;
Metabolomics;
Toxicology;
INDUCED LIVER-INJURY;
CIRCULATING MICRORNAS;
RAT PLASMA;
CHIP;
D O I:
10.1358/dof.2014.39.5.2167003
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The Society for Medicines Research Symposium, sponsored by Amsbio, Pfizer Neusentis and Takeda, was held at the National Heart and Lung Institute, Kensington, London, U.K. The meeting, organized by Wendy Alderton, Julie Holder, Ruth Lock and David Pryde, focused on reducing attrition through the early assessment of drug safety and brought together a range of international experts from both academia and industry to present the new technologies and their applications in early drug safety assessment.
引用
收藏
页码:373 / 377
页数:5
相关论文